Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-049717
Filing Date
2025-04-02
Accepted
2025-04-02 18:29:36
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2939
  Complete submission text file 0000950170-25-049717.txt   4368
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address
Rouan Sarah Kathryn (Reporting) CIK: 0001761366 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 25806751